{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:22:54Z","timestamp":1792660974580,"version":"4.5.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR28626\/BRB\/10\/1672\/2018"],"award-info":[{"award-number":["BT\/PR28626\/BRB\/10\/1672\/2018"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.heliyon.2021.e06836","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T09:49:53Z","timestamp":1618825793000},"page":"e06836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4460-3949","authenticated-orcid":false,"given":"Sundarasamy","family":"Mahalingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9211-5312","authenticated-orcid":false,"given":"John","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7690-7029","authenticated-orcid":false,"given":"Ziyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devivasha","family":"Bordoloi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaniambadi S.","family":"Kalyanaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alagarsamy","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6807-2065","authenticated-orcid":false,"given":"Kar","family":"Muthumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2021.e06836_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/v12030254","article-title":"Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies","volume":"12","author":"Ahmed","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.heliyon.2021.e06836_bib2","doi-asserted-by":"crossref","first-page":"138764","DOI":"10.1016\/j.scitotenv.2020.138764","article-title":"First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community","volume":"728","author":"Ahmed","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.heliyon.2021.e06836_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","article-title":"B\u00a0cell memory: building two walls of protection against pathogens","volume":"20","author":"Akkaya","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A\u00a0serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib5","series-title":"A\u00a0Serological Assay to Detect SARS-CoV-2 Seroconversion in Humans","author":"Amanat","year":"2020"},{"key":"10.1016\/j.heliyon.2021.e06836_bib6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19","volume":"75","author":"Azkur","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.heliyon.2021.e06836_bib7","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.jinf.2020.04.005","article-title":"Saliva is a reliable tool to detect SARS-CoV-2","volume":"81","author":"Azzi","year":"2020","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.heliyon.2021.e06836_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2020.08.078","article-title":"Kinetics of viral clearance and antibody production across age groups in children with severe acute respiratory syndrome coronavirus 2 infection","author":"Bahar","year":"2020","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.heliyon.2021.e06836_bib9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1912658","article-title":"Surgery versus conservative care for persistent sciatica lasting 4 to 12 months","volume":"382","author":"Bailey","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01136-20","article-title":"Performance of abbott ID Now COVID-19 rapid nucleic acid amplification test using nasopharyngeal swabs transported in viral transport media and dry nasal swabs in a New York city academic institution","volume":"58","author":"Basu","year":"2020","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib11","doi-asserted-by":"crossref","first-page":"104468","DOI":"10.1016\/j.jcv.2020.104468","article-title":"Evaluation of the EUROIMMUN anti-SARS-CoV-2 ELISA assay for detection of IgA and IgG antibodies","volume":"129","author":"Beavis","year":"2020","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13525","article-title":"SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate","author":"Becerra-Flores","year":"2020","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.heliyon.2021.e06836_bib14","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI138745","article-title":"Deployment of convalescent plasma for the prevention and treatment of COVID-19","volume":"130","author":"Bloch","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.heliyon.2021.e06836_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01694","article-title":"Techniques to study antigen-specific B cell responses","volume":"10","author":"Boonyaratanakornkit","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s41587-020-0513-4","article-title":"CRISPR-Cas12-based detection of SARS-CoV-2","volume":"38","author":"Broughton","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib17","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.3389\/fimmu.2018.02673","article-title":"Long-lived plasma cells in mice and men","volume":"9","author":"Brynjolfsson","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1472-6750-5-22","article-title":"A\u00a0simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins","volume":"5","author":"Burbelo","year":"2005","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(21)00298-1","article-title":"Understanding variants of SARS-CoV-2","volume":"397","author":"Burki","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2021.e06836_bib20","article-title":"A\u00a0Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features","author":"Cai","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2021.e06836_bib22","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","author":"Casadevall","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.heliyon.2021.e06836_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.heliyon.2021.e06836_bib24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1473-3099(20)30141-9","article-title":"Convalescent plasma as a potential therapy for COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1473-3099(20)30235-8","article-title":"SARS-CoV-2: virus dynamics and host response","volume":"20","author":"Chen","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib26","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.2337\/dci20-0035","article-title":"Response to Comment on Chen et\u00a0al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication","volume":"43","author":"Chen","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06836_bib165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000507423","article-title":"COVID-19 outbreak: an overview","volume":"64","author":"Ciotti","year":"2019","journal-title":"Chemotherapy"},{"key":"10.1016\/j.heliyon.2021.e06836_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/09546634.2020.1759770","article-title":"Conducting clinical trials during the COVID-19 pandemic","volume":"31","author":"Collier","year":"2020","journal-title":"J.\u00a0Dermatol. Treat."},{"key":"10.1016\/j.heliyon.2021.e06836_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T\u00a0follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2021.e06836_bib30","series-title":"Seroprevalence of SARS-CoV-2 Among Children Visiting a Hospital during the Initial Seattle Outbreak","author":"Dingens","year":"2020"},{"key":"10.1016\/j.heliyon.2021.e06836_bib31","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib32","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.heliyon.2021.e06836_bib33","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-020-0732-3","article-title":"Immune-mediated approaches against COVID-19","volume":"15","author":"Florindo","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijid.2020.10.074","article-title":"The art of the possible in approaching efficacy trials for COVID19 convalescent plasma","volume":"102","author":"Focosi","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib35","doi-asserted-by":"crossref","first-page":"12524","DOI":"10.1073\/pnas.2007433117","article-title":"Reply to Sanchez-Pacheco et\u00a0al., Chookajorn, and Mavian et\u00a0al.: explaining phylogenetic network analysis of SARS-CoV-2 genomes","volume":"117","author":"Forster","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2021.e06836_bib36","series-title":"Homologous Protein Domains in SARS-CoV-2 and Measles, Mumps and Rubella Viruses: Preliminary Evidence that MMR Vaccine Might Provide protection against COVID-19","author":"Franklin","year":"2020"},{"key":"10.1016\/j.heliyon.2021.e06836_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2021.e06836_bib38","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S2213-2600(20)30162-4","article-title":"Monitoring the COVID-19 epidemic in the context of widespread local transmission","volume":"8","author":"Garcia-Basteiro","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A\u00a0sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2","volume":"27","author":"Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.heliyon.2021.e06836_bib40","series-title":"SARS-CoV-2 Serological Analysis of COVID-19 Hospitalized Patients, Pauci-Symptomatic Individuals and Blood Donors","author":"Grzelak","year":"2020"},{"key":"10.1016\/j.heliyon.2021.e06836_bib41","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib42","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling early humoral response to diagnose novel coronavirus disease (COVID-19)","volume":"71","author":"Guo","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib43","series-title":"SARS-CoV-2 Infection Severity Is Linked to superior Humoral Immunity against the Spike","author":"Guthmiller","year":"2020"},{"key":"10.1016\/j.heliyon.2021.e06836_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202048715","article-title":"LIPS method for the detection of SARS-CoV-2 antibodies to spike and nucleocapsid proteins","author":"Haljasmagi","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2021.e06836_bib46","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib47","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/23744235.2020.1759817","article-title":"Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study","volume":"52","author":"Hou","year":"2020","journal-title":"Inf. Disp."},{"key":"10.1016\/j.heliyon.2021.e06836_bib48","first-page":"346","article-title":"Antibodies to human coronaviruses 229E and OC43 in the population of C.R","volume":"34","author":"Hruskova","year":"1990","journal-title":"Acta Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib49","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1038\/s41467-020-18450-4","article-title":"A\u00a0systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity","volume":"11","author":"Huang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2021.e06836_bib50","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2021.e06836_bib51","doi-asserted-by":"crossref","first-page":"101606","DOI":"10.1016\/j.tmaid.2020.101606","article-title":"Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: a retrospective single center analysis","author":"Huang","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e06836_bib167","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.heliyon.2021.e06836_bib52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/vim.2020.0055","article-title":"B\u00a0cells, viruses, and the SARS-CoV-2\/COVID-19 pandemic of 2020","volume":"33","author":"Hurwitz","year":"2020","journal-title":"Viral Immunol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib53","doi-asserted-by":"crossref","first-page":"104393","DOI":"10.1016\/j.jcv.2020.104393","article-title":"Clinical evaluation of an immunochromatographic IgM\/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19","volume":"128","author":"Imai","year":"2020","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib54","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.18.2000603","article-title":"Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples","volume":"25","author":"Jaaskelainen","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.heliyon.2021.e06836_bib55","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1016\/j.jmb.2020.04.009","article-title":"Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically sensitive activation loop","volume":"432","author":"Jaimes","year":"2020","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/v12040372","article-title":"Virology, epidemiology, pathogenesis, and control of COVID-19","volume":"12","author":"Jin","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.heliyon.2021.e06836_bib57","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3389\/fimmu.2016.00401","article-title":"Understanding immune cells in tertiary lymphoid organ development: it is all starting to come together","volume":"7","author":"Jones","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib58","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3389\/fimmu.2019.00721","article-title":"The maintenance of memory plasma cells","volume":"10","author":"Khodadadi","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.heliyon.2021.e06836_bib166","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3851\/IMP3243","article-title":"Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience","volume":"23","author":"Ko","year":"2018","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.heliyon.2021.e06836_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10050319","article-title":"Antibody tests in detecting SARS-CoV-2 infection: a meta-analysis","volume":"10","author":"Kontou","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.heliyon.2021.e06836_bib60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nano.2005.06.004","article-title":"Role of nanotechnology in targeted drug delivery and imaging: a concise review","volume":"1","author":"Koo","year":"2005","journal-title":"Nanomedicine"},{"key":"10.1016\/j.heliyon.2021.e06836_bib61","series-title":"Spike Mutation Pipeline Reveals the Emergence of a More Transmissible Form of SARS-CoV-2","author":"Korber","year":"2020"},{"key":"10.1016\/j.heliyon.2021.e06836_bib62","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2021.e06836_bib63","doi-asserted-by":"crossref","first-page":"104437","DOI":"10.1016\/j.jcv.2020.104437","article-title":"SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients","volume":"128","author":"Korth","year":"2020","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib64","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2021.e06836_bib65","doi-asserted-by":"crossref","first-page":"104394","DOI":"10.1016\/j.jcv.2020.104394","article-title":"Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG","volume":"128","author":"Kruttgen","year":"2020","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00505-20","article-title":"Comparative genomic analysis of rapidly evolving SARS-CoV-2 reveals mosaic pattern of phylogeographical distribution","volume":"5","author":"Kumar","year":"2020","journal-title":"mSystems"},{"key":"10.1016\/j.heliyon.2021.e06836_bib67","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.rbmo.2020.06.001","article-title":"Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays","volume":"41","author":"La Marca","year":"2020","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.heliyon.2021.e06836_bib68","series-title":"Evaluation of Nine Commercial SARS-CoV-2 Immunoassays","author":"Lassauni\u00e8re","year":"2020"},{"key":"10.1016\/j.heliyon.2021.e06836_bib69","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fimmu.2020.00879","article-title":"Serological approaches for COVID-19: epidemiologic perspective on surveillance and control","volume":"11","author":"Lee","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib70","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/s41467-020-16048-4","article-title":"Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig","volume":"11","author":"Lei","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2021.e06836_bib71","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial","volume":"324","author":"Li","year":"2020","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.heliyon.2021.e06836_bib72","article-title":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)","author":"Li","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2021.e06836_bib73","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib74","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41591-020-1088-9","article-title":"Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study","volume":"26","author":"Liu","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib75","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41586-020-2271-3","article-title":"Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals","volume":"582","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2021.e06836_bib76","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.heliyon.2021.e06836_bib77","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib78","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib79","series-title":"Serology Characteristics of SARS-CoV-2 Infection since the Exposure and post Symptoms Onset","author":"Lou","year":"2020"},{"key":"10.1016\/j.heliyon.2021.e06836_bib80","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2021.e06836_bib81","article-title":"Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity","author":"Lynch","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib82","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41423-020-0474-z","article-title":"Serum IgA, IgM, and IgG responses in COVID-19","volume":"17","author":"Ma","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2020.08.009","article-title":"High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies","author":"Mairesse","year":"2020","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.heliyon.2021.e06836_bib84","doi-asserted-by":"crossref","first-page":"104500","DOI":"10.1016\/j.jcv.2020.104500","article-title":"Evaluation of rapid antigen test for detection of SARS-CoV-2 virus","volume":"129","author":"Mak","year":"2020","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","author":"Mercado","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2021.e06836_bib86","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3389\/fmicb.2020.01800","article-title":"Geographic and genomic distribution of SARS-CoV-2 mutations","volume":"11","author":"Mercatelli","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib87","doi-asserted-by":"crossref","first-page":"100099","DOI":"10.1016\/j.xcrm.2020.100099","article-title":"Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant","volume":"1","author":"Mlcochova","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib88","doi-asserted-by":"crossref","first-page":"104413","DOI":"10.1016\/j.jcv.2020.104413","article-title":"Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies","volume":"128","author":"Montesinos","year":"2020","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib89","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00772-20","article-title":"Detection of SARS-CoV-2 by use of the cepheid Xpert xpress SARS-CoV-2 and roche cobas SARS-CoV-2 assays","volume":"58","author":"Moran","year":"2020","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib90","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jviromet.2006.09.024","article-title":"Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43","volume":"139","author":"Mourez","year":"2007","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.heliyon.2021.e06836_bib91","article-title":"Reinfection of severe acute respiratory syndrome coronavirus 2 in an immunocompromised patient: a case report","author":"Mulder","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2020.08.011","article-title":"Positive aspects, negative aspects and limitations of plasma therapy with special reference to COVID-19","author":"Nagoba","year":"2020","journal-title":"J.\u00a0Infect. Publ. Health"},{"key":"10.1016\/j.heliyon.2021.e06836_bib93","doi-asserted-by":"crossref","first-page":"766","DOI":"10.7326\/L20-0175","article-title":"COVID-19 and the risk to health care workers: a case report","volume":"172","author":"Ng","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib94","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2020.04.023","article-title":"Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals","volume":"52","author":"Ni","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2021.e06836_bib95","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11357-020-00186-0","article-title":"SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes","volume":"42","author":"Nikolich-Zugich","year":"2020","journal-title":"Geroscience"},{"key":"10.1016\/j.heliyon.2021.e06836_bib96","series-title":"Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients","author":"Norman","year":"2020"},{"key":"10.1016\/j.heliyon.2021.e06836_bib97","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41420-020-0275-2","article-title":"SARS-CoV-2 infection serology: a useful tool to overcome lockdown?","volume":"6","author":"Nuccetelli","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib98","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3201\/eid2607.200841","article-title":"Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients","volume":"26","author":"Okba","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib99","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2021.e06836_bib100","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1515\/cclm-2020-0443","article-title":"Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM\/IgG and antibody kinetics","volume":"58","author":"Padoan","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib101","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cca.2020.04.026","article-title":"IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: a longitudinal study","volume":"507","author":"Padoan","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.heliyon.2021.e06836_bib102","doi-asserted-by":"crossref","first-page":"104868","DOI":"10.1016\/j.antiviral.2020.104868","article-title":"Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro","author":"Pan","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.heliyon.2021.e06836_bib103","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/ajt.15941","article-title":"COVID-19 in solid organ transplant recipients: initial report from the US epicenter","volume":"20","author":"Pereira","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.heliyon.2021.e06836_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2021.e06836_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008817","article-title":"Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings","volume":"16","author":"Pickering","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2021.e06836_bib106","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1038\/s41467-020-16638-2","article-title":"Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients","volume":"11","author":"Poh","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2021.e06836_bib107","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2021.e06836_bib108","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib109","doi-asserted-by":"crossref","first-page":"100126","DOI":"10.1016\/j.xcrm.2020.100126","article-title":"Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike","volume":"1","author":"Prevost","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib110","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25767","article-title":"Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19","author":"Qu","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9030231","article-title":"SARS-CoV-2 and coronavirus disease 2019: what we know so far","volume":"9","author":"Rabi","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.heliyon.2021.e06836_bib112","series-title":"COVID-19 Serology at Population Scale: SARS-CoV-2-specific Antibody Responses in Saliva","author":"Randad","year":"2020"},{"key":"10.1016\/j.heliyon.2021.e06836_bib113","doi-asserted-by":"crossref","first-page":"102554","DOI":"10.1016\/j.autrev.2020.102554","article-title":"Convalescent plasma in Covid-19: possible mechanisms of action","volume":"19","author":"Rojas","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.heliyon.2021.e06836_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2107","article-title":"Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: comparison with SARS and MERS","volume":"30","author":"Rokni","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib115","doi-asserted-by":"crossref","DOI":"10.1128\/MRA.00568-20","article-title":"Complete genome sequence of a novel coronavirus (SARS-CoV-2) isolate from Bangladesh","volume":"9","author":"Saha","year":"2020","journal-title":"Microbiol. Resour. Announc."},{"key":"10.1016\/j.heliyon.2021.e06836_bib116","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.immuni.2020.07.005","article-title":"Lessons for COVID-19 immunity from other coronavirus infections","volume":"53","author":"Sariol","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2021.e06836_bib117","article-title":"Convalescent plasma therapy in four critically ill pediatric patients with coronavirus disease 2019: a case series","volume":"2","author":"Schwartz","year":"2020","journal-title":"Crit. Care Explor."},{"key":"10.1016\/j.heliyon.2021.e06836_bib118","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/CVI.00124-08","article-title":"Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population","volume":"15","author":"Severance","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib119","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","author":"Shen","year":"2020","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.heliyon.2021.e06836_bib120","first-page":"614","article-title":"[Progress and challenge of vaccine development against 2019-novel coronavirus (2019-nCoV)]","volume":"54","author":"Shi","year":"2020","journal-title":"Zhonghua Yufang Yixue Zazhi"},{"key":"10.1016\/j.heliyon.2021.e06836_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.09.1484","article-title":"Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh","author":"Shirin","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib122","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1093\/labmed\/lmaa039","article-title":"Types of assays for SARS-CoV-2 testing: a review","volume":"51","author":"Smithgall","year":"2020","journal-title":"Lab. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib123","doi-asserted-by":"crossref","first-page":"104428","DOI":"10.1016\/j.jcv.2020.104428","article-title":"Comparison of cepheid Xpert xpress and abbott ID Now to roche cobas for the rapid detection of SARS-CoV-2","volume":"128","author":"Smithgall","year":"2020","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib124","doi-asserted-by":"crossref","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 seroconversion in humans: a detailed protocol for a serological assay, antigen production, and test setup","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib125","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.13.2000305","article-title":"Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe","volume":"25","author":"Stefanelli","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.heliyon.2021.e06836_bib126","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study","volume":"396","author":"Stringhini","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2021.e06836_bib127","doi-asserted-by":"crossref","DOI":"10.1093\/jalm\/jfaa079","article-title":"Longitudinal monitoring of SARS-CoV-2 IgM and IgG seropositivity to detect COVID-19","author":"Suhandynata","year":"2020","journal-title":"J.\u00a0Appl. Lab. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib128","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/jalm\/jfaa079","article-title":"Longitudinal monitoring of SARS-CoV-2 IgM and IgG seropositivity to detect COVID-19","volume":"5","author":"Suhandynata","year":"2020","journal-title":"J.\u00a0Appl. Lab. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib129","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jmv.25735","article-title":"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis","volume":"92","author":"Sun","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.heliyon.2021.e06836_bib131","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00797-20","article-title":"The role of antibody testing for SARS-CoV-2: is there one?","volume":"58","author":"Theel","year":"2020","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib132","article-title":"Genomic evidence for reinfection with SARS-CoV-2: a case study","author":"Tillett","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib133","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","volume":"20","author":"To","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib134","doi-asserted-by":"crossref","first-page":"104351","DOI":"10.1016\/j.meegid.2020.104351","article-title":"Emergence of genomic diversity and recurrent mutations in SARS-CoV-2","volume":"83","author":"van Dorp","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2021.e06836_bib136","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00375-20","article-title":"A\u00a0method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays","volume":"58","author":"Wang","year":"2020","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib137","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.heliyon.2021.e06836_bib138","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(20)30633-4","article-title":"Clinical course and mortality risk of severe COVID-19","volume":"395","author":"Weiss","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2021.e06836_bib139","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Wolfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2021.e06836_bib140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jinf.2020.06.023","article-title":"Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2","volume":"81","author":"Wu","year":"2020","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.heliyon.2021.e06836_bib141","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2020.1291","article-title":"Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in hubei province, China","author":"Wu","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib142","article-title":"Antibody detection and dynamic characteristics in patients with COVID-19","author":"Xiang","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib143","doi-asserted-by":"crossref","first-page":"104346","DOI":"10.1016\/j.jcv.2020.104346","article-title":"Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study","volume":"127","author":"Xiao","year":"2020","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib144","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/ijmr.IJMR_663_20","article-title":"Full-genome sequences of the first two SARS-CoV-2 viruses from India","volume":"151","author":"Yadav","year":"2020","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.heliyon.2021.e06836_bib146","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.113.1.e73","article-title":"Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis","volume":"113","author":"Yeh","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.heliyon.2021.e06836_bib147","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202000152","article-title":"Molecular targets for the testing of COVID-19","volume":"15","author":"Yong","year":"2020","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.heliyon.2021.e06836_bib148","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01526-2020","article-title":"Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients","author":"Yu","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2021.e06836_bib149","series-title":"SARS-CoV-2 Spike Protein Variant D614G Increases Infectivity and Retains Sensitivity to Antibodies that Target the Receptor Binding Domain","author":"Yurkovetskiy","year":"2020"},{"key":"10.1016\/j.heliyon.2021.e06836_bib150","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib151","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/v12111274","article-title":"A\u00a0cell-based ELISA to improve the serological analysis of anti-SARS-CoV-2 IgG","volume":"12","author":"Zarletti","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.heliyon.2021.e06836_bib152","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.0878","article-title":"Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in wuhan, China","author":"Zeng","year":"2020","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.heliyon.2021.e06836_bib153","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abb8001","article-title":"Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2021.e06836_bib154","doi-asserted-by":"crossref","DOI":"10.1093\/pcmedi\/pbaa031","article-title":"SARS-CoV-2 reinfection in two patients who have recovered from COVID-19","author":"Zhang","year":"2020","journal-title":"Precision Clin. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2020.03.035","article-title":"A\u00a0genomic perspective on the origin and emergence of SARS-CoV-2","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2021.e06836_bib156","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib157","article-title":"Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib158","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib159","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41423-020-0385-z","article-title":"Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.heliyon.2021.e06836_bib160","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","article-title":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003","volume":"362","author":"Zhong","year":"2003","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.heliyon.2021.e06836_bib168","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMc070359","article-title":"Treatment with convalescent plasma for influenza A (H5N1) infection","volume":"357","author":"Zhou","year":"2007","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.heliyon.2021.e06836_bib161","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2021.e06836_bib162","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.7150\/ijbs.45123","article-title":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2","volume":"16","author":"Zhou","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2021.e06836_bib163","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/1471-2334-13-433","article-title":"First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood","volume":"13","author":"Zhou","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e06836_bib164","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A\u00a0novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021009397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021009397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:46:00Z","timestamp":1752583560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844021009397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":167,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2405844021009397"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06836","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e06836"}}